P41 Cost-Effectiveness Modeling of CAR-T Cell Therapies in Hematologic Malignancies: Insights From NICE and CDA-AMC Appraisals
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.080
https://www.valueinhealthjournal.com/article/S1098-3015(25)02637-3/fulltext
Title :
P41 Cost-Effectiveness Modeling of CAR-T Cell Therapies in Hematologic Malignancies: Insights From NICE and CDA-AMC Appraisals
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)02637-3&doi=10.1016/j.jval.2025.09.080
First page :
Section Title :
Open access? :
No
Section Order :
11094